NORSPAN

This brand name is authorized in Australia, Austria, Ecuador, Estonia, Finland, Germany, Hong Kong SAR China, Japan, Lithuania, New Zealand.

Active ingredients

The drug NORSPAN contains one active pharmaceutical ingredient (API):

1	Buprenorphine UNII 40D3SCR4GZ - BUPRENORPHINE
	Buprenorphine is an opioid partial agonist/antagonist which attaches itself to the μ (mu) and κ (kappa) receptors of the brain. Its activity in opioid maintenance treatment is attributed to its slowly reversible link with the μ receptors which, over a prolonged period, minimises the need of illicit opioids for patients with opioid dependence.
	Read more about Buprenorphine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NORSPAN Patch	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02AE01	Buprenorphine	N Nervous system → N02 Analgesics → N02A Opioids → N02AE Oripavine derivatives
Discover more medicines within N02AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10746N, 10755C, 10756D, 10770W, 10948F, 10949G, 10953L, 10957Q, 10959T, 10964C, 10970J, 8865N, 8866P, 8867Q
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00683602, 00683619, 00683660, 00684317, 00684346, 00684352, 03323258, 03323264, 03323287, 10005843, 10005866, 10005872, 10179684, 10179690, 10179709, 10179715, 10179721, 10179738, 10179744, 10179750, 10179767, 10226099, 10226107, 10226113, 10226136, 10226142, 10226159, 10226165, 10226171, 10226188, 11525467, 11525473, 11525496, 11525504, 11525510, 11525527, 16003555, 16003561, 17532994, 17533002, 17533019, 17533025, 17533031
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	1648-MEE-0116, 1788-MEE-0216, 2244-MEE-0616
EE	Ravimiamet	1305885, 1305908, 1305919, 1305920, 1305931, 1305942, 1305953, 1305964, 1305975, 1305986, 1305997, 1306000, 1306011, 1306022, 1306033, 1306044, 1306055, 1306066, 1306077, 1306088, 1306099, 1306101, 1306112, 1306123
FI	Lääkealan turvallisuus- ja kehittämiskeskus	068046, 068112, 149386, 149397, 149408, 183264, 433624, 456128
HK	Department of Health Drug Office	61495, 61496, 61497
JP	医薬品医療機器総合機構	1149704S1020, 1149704S2027, 1149704S3023
LT	Valstybinė vaistų kontrolės tarnyba	1026205, 1026206, 1026207, 1033071, 1033072, 1033073, 1033074, 1033075, 1033076, 1033077, 1033078, 1033079, 1033080, 1033081, 1033082, 1033083, 1033084, 1033085, 1033086, 1033087, 1033088, 1033089, 1033090, 1033091
NZ	Medicines and Medical Devices Safety Authority	12436, 12437, 12438